TLR9 Expression in Uterine Cervical Lesions of Uyghur Women Correlate with Cervical Cancer Progression and Selective Silencing of Human Papillomavirus 16 E6 and E7 Oncoproteins in Vitro |
Hao, Yi
(The Affiliated Tumor Hospital of Xinjiang Medical University)
Yuan, Jian-Ling (The Affiliated Tumor Hospital of Xinjiang Medical University) Abudula, Abulizi (Xinjiang Key Laboratory of Molecular Biology and Endemic Diseases, Xinjiang Medical University) Hasimu, Axiangu (Department of Pathology, Xinjiang Medical University) Kadeer, Nafeisha (Xinjiang Key Laboratory of Molecular Biology and Endemic Diseases, Xinjiang Medical University) Guo, Xia (Xinjiang Key Laboratory of Molecular Biology and Endemic Diseases, Xinjiang Medical University) |
1 | Akira S, Takeda K (2004). Toll-like receptor signalling. Nat Rev Immunol, 4, 499-511. DOI ScienceOn |
2 | Akira S, Uematsu S, Takeuchi O (2006). Pathogen recognition and innate immunity. Cell, 124, 783-01. DOI ScienceOn |
3 | Cohen J (2005). Pubic health High hopes and dilemmas for a cervical cancer vaccine. Science, 308, 618-21. DOI |
4 | Dolganiuc A, Garcia C, Kodys K, et al (2006). Distinct Toll-like receptor expression in monocytes and T cells in chronic HCV infection. World J Gastroenterol, 12, 1198-04. |
5 | Daud II, Scott ME, Ma Y, et al (2011). Association between tolllike receptor expression and human papillomavirus type 16 persistence. Int J Cancer, 128, 879-86. DOI |
6 | Ferlay J, Autier P, Boniol M, et al (2007). Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol, 18, 581-92. |
7 | Frisch M, Biggar RJ, Goedert JJ (2000). Human papillomavirusassociated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst, 92, 1500-10. DOI |
8 | Groskreutz DJ, Monick MM, Powers LS, et al (2006). Respiratory syncytial virus induces TLR3 protein and protein kinase R: leading to increased double-stranded RNA responsiveness in airway epithelial cells. J Immunol, 176, 1733-40. DOI |
9 | Huang B, Zhao J, Unkeless JC, et al (2008). TLR signaling by tumor and immune cells: a double-edged sword. Oncogene, 27, 218-24. DOI ScienceOn |
10 | Horsmans Y, Berg T, Desager JP, et al (2005). Isatoribine an agonist of TLR7: reduces plasma virus concentration in chronic hepatitis C infection. Hepatology, 42, 724-31. DOI ScienceOn |
11 | Hasan UA, Bates E, Takeshita F, et al (2007). TLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16. J Immunol, 178, 3186-97. DOI |
12 | IIvesaro JM, Merrell MA, Swain TM, et al (2007). Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro. Prostate, 67, 774-81. DOI ScienceOn |
13 | Krieg AM (2008). Toll-like receptor 9 (TLR9) agonists in the treatment of cancer. Oncogene, 27, 161-7. DOI ScienceOn |
14 | Kim WY, Lee JW, Choi JJ, et al (2008). Increased expression of Toll-like receptor 5 during progression of cervical neoplasia. Int J Gynecol Cancer, 18, 300-5. DOI ScienceOn |
15 | LIU KJ, LIU JW, LI XR, et al (2008). Epidemiology study of risk factors on Uigur and Han cervical cancer in Xinjiang (J). J Xinjiang Med Univ, 31, 1335-8. |
16 | Lenert PS (2010). Classification, mechanisms of action and therapeutic applications of inhibitory oligonucleotides for toll-like receptors (TLR) 7 and 9. Mediators Inflamm, 2010, 986596. |
17 | Lee JW, Choi JJ, Seo ES, et al (2007). Increased toll-like receptor 9 expression in cervical neoplasia. Mol Carcinog, 46, 941-7. DOI ScienceOn |
18 | Matijevic T, Pavelic J (2010). Toll-like receptors: cost or benefit for cancer. Curr Pharm, 16, 1081-90. DOI ScienceOn |
19 | Mishra A, Bharti AC, Varghese P, et al (2006). Differential expression and activation of NF-kappaB family proteins during oral carcinogenesis: role of high risk human papillomavirus infection. Int J Cancer, 119, 2840-50. DOI |
20 | Mukherjee S, Siddiqui MA, Dayal S, et al (2014). Epigallocatechin-3-gallate suppresses proinflammatory cytokines and chemokines induced by Toll-like receptor 9 agonists in prostate cancer cells. J Inflamm Res, 17, 89-101. |
21 | Stanley MA, Pett MR, Coleman N (2007). HPV: from infection to cancer. Biochem Soc Trans, 35, 1456-60. DOI |
22 | Nees M, Geoghegan JM, Hyman T, et al (2001). Papillomavirus type 16 oncogenes down-regulate expression of interferonresponsive genes and up-regulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes. J Virol, 75, 4283-96. DOI ScienceOn |
23 | Ostor AG (1993). Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol, 12, 186-92. DOI ScienceOn |
24 | Ren T, Wen ZK, Liu ZM, et al (2007). Functional expression of TLR9 is associated to the metastatic potential of human lung cancer cell: functional active role of TLR9 on tumor metastasis. Cancer Biol Ther, 6, 1704-9. DOI |
25 | Sato Y, Goto Y, Narita N, et al (2009). Cancer cells expressing toll-like receptors and the tumor microenvironment. Cancer Microenviron, 2, 205-14. DOI |
26 | Suzuke L, Peng YH, Zhou K, et al (2006). The analysis of pathogenetic tendency of cervical cancer in various ethnic women in Xinjiang. J Xinjiang Med Univ, 29, 569-71. |
27 | Tezcan S, Ozgur D, Ulger M, et al (2014). Human papillomavirus genotype distribution and E6/ E7 oncogene expression in Turkish women with cervical cytological findings. Asian Pac J Cancer Prev, 15, 3997-4003. 과학기술학회마을 DOI |
28 | Tommasino M (2001). Early genes of human papillomaviruses: In Encyclopedic Reference of Cancer. Springer-Verlag, Heidelberg, 262-272. |
29 | Takeshita F, Gursel I, Ishii KJ, et al (2004). Signal transduction pathways mediated by the interaction of CpG DNA with Toll-like receptor 9. Semin Immunol, 16, 17-22. DOI ScienceOn |
30 | Takeshita F, Suzuki K, Sasaki S, et al (2004). Transcriptional regulation of the human TLR9 gene. J Immunol, 173, 2552-61. DOI |
31 | Wu XM, Liu X, Jiao QF, et al (2014). Cytotoxic T lymphocytes elicited by dendritic cell-targeted delivery of human papillomavirus type-16 E6/E7 fusion gene exert lethal effects on CaSki cells. Asian Pac J Cancer Prev, 15, 2447-51. 과학기술학회마을 DOI |
32 | Wang D, Xiao PL, Duan HX, et al (2012). Peptidoglycans Promotes Human Leukemic THP-1 Cell Apoptosis and Differentiation. Asian Pacific J Cancer Prev, 13, 6409-13. 과학기술학회마을 DOI |
33 | Yang BH, Bray FI, Parkin DM, et al (2004). Cervical cancer as a priority for prevention in different world regions: an evaluation using years of life lost. Int J Cancer, 109, 418-24. DOI ScienceOn |
34 | Wang D, Xiao PL, Duan HX, et al (2012). Lack of association of three common polymorphisms in Toll-like receptors (TLRs), TLR2+597T>C, +1350C>T and Arg753Gln with cancer risk: a meta-analysis. Asian Pac J Cancer Prev, 14, 5871-76. 과학기술학회마을 DOI |
35 | Zhang GQ, LIU KJ, Lai XJ, et al (2003). Distribution of malignant tumor patients in hospital from 1989 to 2002 in the Affiliated Tumor Hospital of Xinjiang Medical University. J Xinjiang Med Univ, 26, 393-5. |
36 | Zhang SQ, Yakup K, Abliz G, et al (2009). The study of the relationships between HPV multiple infection and cervical cancer of Uygur Women in Xinjiang. J Xinjiang Med Univ, 32, 525-8. |
37 | Clifford GM, Smith JS, Plummer M, et al (2003). Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer, 88, 63-73. DOI ScienceOn |